As reported by a field clinical specialist (fcs), during the procedure of a 26 mm sapien 3 ultra valve in the aortic position via transfemoral approach.The 14 fr esheath was prepped and pre-dilated on the back table.It was placed without issue.Difficulty advancing the valve through the white section and non-expandable section of the 14fr e-sheath.After several unsuccessful maneuvers, it was noted that the valve frame tines were poking through the sheath outside of the body.The whole system was removed and a new 14fr esheath was placed and valve was able to be pushed through the sheath easily.It was a successful procedure.
|
The device was not returned to edwards lifesciences for evaluation.Without the device returned for evaluation, visual inspection, functional testing and dimensional analysis were unable to be completed.Imagery was provided from the site and revealed the following: one (1) bent strut at the inflow side protruded through strain relief.Patient's right access vessel had presence of calcification, tortuosity, and undersized vessel.A review of the risk management documentation was performed, and no evidence of product non-conformances or labeling/ifu inadequacies were identified in the evaluation.The complaint was confirmed based on the provided imagery.Available information suggests patient factors (calcification, tortuosity, undersized vessel) and/or procedural factors (excessive manipulation/high push force) likely contributed to the event as reported in the event description and observed in the imaging evaluation.Bent strut, calcification, tortuosity, and undersized vessel were observed.Calcification can reduce the vessel lumen diameter and may increase restriction leading to resistance.Calcification can also result in the creation of sub-optimal angles during delivery system insertion that may lead to resistance.Tortuous patient anatomy can create sub-optimal angles that can lead to non-coaxial alignment between the delivery system with crimped valve and sheath inner lumen.Undersized vessels (e.G.Due to anatomical variation, pre-existing stent or graft, scar tissue, or fibrosis) can create a restricted pathway or constrained condition resulting in difficulty during sheath expansion and increased resistance during the advancement of the delivery system.Excessive device manipulation or high push force can lead to the valve struts interacting with the sheath shaft and result in the strut damage at the valve inflow side.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No ifu/labeling/training manual inadequacies were identified.Therefore, no corrective or preventative action nor product risk assessment is required at this time.
|